 Samrat Roy Choudhury
Concepts (121)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epigenesis, Genetic | 6 | 2025 | 401 | 1.230 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2025 | 201 | 1.140 |
Why?
| | Sulfur | 4 | 2013 | 9 | 1.050 |
Why?
| | Nanoparticles | 4 | 2013 | 127 | 0.940 |
Why?
| | Gene Rearrangement | 1 | 2024 | 76 | 0.810 |
Why?
| | Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 120 | 0.720 |
Why?
| | DNA Methylation | 6 | 2025 | 583 | 0.720 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 224 | 0.690 |
Why?
| | Chromatin | 3 | 2025 | 141 | 0.680 |
Why?
| | Promoter Regions, Genetic | 6 | 2025 | 465 | 0.670 |
Why?
| | Melanoma | 1 | 2023 | 278 | 0.630 |
Why?
| | Aspergillus niger | 2 | 2012 | 6 | 0.550 |
Why?
| | Multiple Myeloma | 3 | 2023 | 2999 | 0.510 |
Why?
| | Mediator Complex | 1 | 2025 | 4 | 0.470 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2025 | 32 | 0.470 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 42 | 0.460 |
Why?
| | Anti-Infective Agents | 2 | 2013 | 106 | 0.450 |
Why?
| | Cell Membrane | 2 | 2017 | 231 | 0.410 |
Why?
| | Fungi | 1 | 2013 | 51 | 0.390 |
Why?
| | Fungicides, Industrial | 1 | 2012 | 7 | 0.380 |
Why?
| | Metabolome | 1 | 2013 | 103 | 0.370 |
Why?
| | CpG Islands | 3 | 2018 | 114 | 0.370 |
Why?
| | Bacteria | 1 | 2013 | 220 | 0.350 |
Why?
| | Lipid Metabolism | 1 | 2012 | 187 | 0.350 |
Why?
| | Oxidative Stress | 2 | 2024 | 809 | 0.340 |
Why?
| | Transcriptome | 1 | 2013 | 363 | 0.330 |
Why?
| | Optogenetics | 2 | 2017 | 6 | 0.330 |
Why?
| | Microscopy, Electron, Scanning | 3 | 2017 | 43 | 0.330 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 111 | 0.310 |
Why?
| | Cryptochromes | 2 | 2016 | 5 | 0.280 |
Why?
| | Zinc Oxide | 1 | 2017 | 4 | 0.260 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 219 | 0.260 |
Why?
| | Hepatocytes | 2 | 2017 | 190 | 0.260 |
Why?
| | Molecular Biology | 1 | 2017 | 27 | 0.260 |
Why?
| | Neural Stem Cells | 1 | 2017 | 26 | 0.260 |
Why?
| | Genes, BRCA1 | 1 | 2016 | 19 | 0.250 |
Why?
| | Mixed Function Oxygenases | 1 | 2016 | 25 | 0.250 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 853 | 0.250 |
Why?
| | Metal Nanoparticles | 1 | 2017 | 66 | 0.250 |
Why?
| | Proto-Oncogene Proteins | 1 | 2016 | 149 | 0.240 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 421 | 0.220 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2014 | 17 | 0.220 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 14 | 0.210 |
Why?
| | Proto-Oncogenes | 1 | 2024 | 27 | 0.210 |
Why?
| | Arabidopsis Proteins | 1 | 2014 | 24 | 0.210 |
Why?
| | Humans | 12 | 2025 | 52114 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2024 | 33 | 0.210 |
Why?
| | Integrin beta Chains | 1 | 2023 | 14 | 0.200 |
Why?
| | Integrins | 1 | 2023 | 31 | 0.200 |
Why?
| | Cytogenetic Analysis | 1 | 2023 | 79 | 0.200 |
Why?
| | Fusarium | 1 | 2011 | 31 | 0.170 |
Why?
| | Histones | 2 | 2025 | 316 | 0.170 |
Why?
| | HeLa Cells | 3 | 2016 | 242 | 0.170 |
Why?
| | Cell Survival | 3 | 2017 | 596 | 0.160 |
Why?
| | Disease Progression | 1 | 2023 | 866 | 0.160 |
Why?
| | DNA | 1 | 2023 | 543 | 0.160 |
Why?
| | Transcription Factors | 1 | 2023 | 564 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2011 | 346 | 0.140 |
Why?
| | Apoptosis | 1 | 2023 | 1117 | 0.140 |
Why?
| | Polyethylene Glycols | 2 | 2012 | 91 | 0.130 |
Why?
| | Mice | 2 | 2023 | 5877 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1101 | 0.100 |
Why?
| | Fatty Acid Desaturases | 1 | 2012 | 9 | 0.100 |
Why?
| | Solanum tuberosum | 1 | 2012 | 5 | 0.090 |
Why?
| | Plant Diseases | 1 | 2012 | 12 | 0.090 |
Why?
| | Animals | 2 | 2023 | 13332 | 0.090 |
Why?
| | Gram-Negative Bacteria | 1 | 2012 | 34 | 0.090 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2012 | 57 | 0.090 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 1418 | 0.090 |
Why?
| | Fungal Proteins | 1 | 2012 | 114 | 0.090 |
Why?
| | Fibroblasts | 1 | 2013 | 358 | 0.090 |
Why?
| | Down-Regulation | 1 | 2012 | 343 | 0.090 |
Why?
| | Cyclin D2 | 1 | 2020 | 21 | 0.080 |
Why?
| | Aneuploidy | 1 | 2020 | 18 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-maf | 1 | 2020 | 19 | 0.080 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 30 | 0.080 |
Why?
| | Histone Code | 1 | 2020 | 32 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2020 | 57 | 0.080 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2020 | 55 | 0.080 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2020 | 75 | 0.080 |
Why?
| | Cell Line | 1 | 2013 | 1018 | 0.080 |
Why?
| | DNA, Neoplasm | 1 | 2020 | 146 | 0.080 |
Why?
| | Mitochondria | 1 | 2013 | 421 | 0.080 |
Why?
| | Plasma Cells | 1 | 2020 | 234 | 0.070 |
Why?
| | Translocation, Genetic | 1 | 2020 | 265 | 0.070 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2018 | 3 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 328 | 0.070 |
Why?
| | Gene Library | 1 | 2018 | 42 | 0.070 |
Why?
| | Quality Control | 1 | 2018 | 98 | 0.070 |
Why?
| | Cell Nucleus Size | 1 | 2017 | 1 | 0.070 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 16 | 0.070 |
Why?
| | Actin Cytoskeleton | 1 | 2017 | 22 | 0.070 |
Why?
| | Carcinogens, Environmental | 1 | 2017 | 22 | 0.070 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 69 | 0.070 |
Why?
| | Light | 1 | 2017 | 51 | 0.070 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2017 | 89 | 0.070 |
Why?
| | Oxidoreductases | 1 | 2017 | 56 | 0.060 |
Why?
| | Telomeric Repeat Binding Protein 1 | 1 | 2016 | 2 | 0.060 |
Why?
| | Telomere Homeostasis | 1 | 2016 | 11 | 0.060 |
Why?
| | Chromosomes | 1 | 2016 | 28 | 0.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 174 | 0.060 |
Why?
| | Telomerase | 1 | 2016 | 26 | 0.060 |
Why?
| | MCF-7 Cells | 1 | 2016 | 62 | 0.060 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 57 | 0.060 |
Why?
| | HEK293 Cells | 1 | 2017 | 231 | 0.060 |
Why?
| | Telomere | 1 | 2016 | 39 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2016 | 60 | 0.060 |
Why?
| | Genomics | 1 | 2018 | 265 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 181 | 0.060 |
Why?
| | Luminescent Proteins | 1 | 2014 | 48 | 0.050 |
Why?
| | Arabidopsis | 1 | 2014 | 24 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 173 | 0.050 |
Why?
| | Spectrometry, X-Ray Emission | 1 | 2011 | 7 | 0.040 |
Why?
| | Thermogravimetry | 1 | 2011 | 7 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2011 | 28 | 0.040 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 24 | 0.040 |
Why?
| | Particle Size | 1 | 2011 | 78 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2011 | 554 | 0.040 |
Why?
| | beta-Lactamases | 1 | 2012 | 17 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2012 | 51 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2012 | 270 | 0.020 |
Why?
|
|
Roy Choudhury's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|